Bone-chilling temperatures couldn’t keep the crowds away from Takeda’s Kendall Square campus on Tuesday to celebrate a milestone for the Japanese drugmaker’s new R&D tower. More than 250 ...

The streamer just released the complete list of titles coming in February 2025, and along with new licensed TV series and movies, more than four dozen new and returning Netflix originals are set to ...

Takeda-backed Ascentage Pharma Group (AAPG) (OTCPK:ASPHF), (OTCPK:AAPGV) which is developing treatments for blood cancer, has set terms for a $170M U.S. initial public offering. In an SEC filing ...

See Correction/Clarification at the end of this article. After layoffs in 2024, Takeda is gearing up for a big 2025 that includes preparations to launch three new medicines, hiring, and finishing ...

Amid a rapidly evolving macroenvironment, Takeda is changing up its R&D priorities and investment strategy. “There's an evolution of our economic model that starts with [the] IRA (Inflation ...

In connection with the effectiveness of the agreement, Takeda will make an upfront payment to the Company of $200.0 million. About Keros Therapeutics, Inc. Keros is a clinical-stage ...

the TV landscape is littered with canceled TV shows and one-season wonders. While we hope – fingers crossed – the situation isn't as bad as the 2024 bloodbath that saw shows such as Kaos ...

“I know what the life-sciences industry does for people firsthand. We are just so excited and so happy to see Takeda continue to grow in our neighborhood.” After a series of photo ops in front of the ...

While massive hits like “Stranger Things” and “The Handmaid’s Tale” are returning with new seasons in 2025, every week, new series are premiering and old favorites are launching on platforms. Using ...

When he undergoes a radical cosmetic procedure, Edward feels like a different man, until a confident doppelganger of his former self shows up, and begins living the life Edward always dreamed of.